. >>> coming up, setback for astrazeneca oxford university vaccine in south africa. details next >>> welcome back to "street signs," everybody. the astrazeneca/oxford university vaccine is good against the covid-19 the vaccine had similar efficacy against the variant first found in september south africa has stopped the new rollout after a new study found it offers minimal protection against the new strain of covid-19 variant there there's a look at european pharma more broadly. stocks are trading more in line with pharma. coming back to the data released over the weekend, in particular yesterday's preprint study from university of oxford, the key takeaway from this release is that the vaccine is proven to be just minimally effective in preventing mild to moderate covid-19 in the south african study, but the study was not able to determine whether the vaccine is effective against preventing severe covid. the study was based on 2,000 participants average age 31 years old. but for me, the key message here is the rhetoric within the release that scientists are optimistic

the astrazeneca vaccine has a mild impact on massive disease, attacks substantial disease but mild disease not so much. which tackles infections, we've been speaking to a researcher at oxford universityine. >> i think we should be concerned about the variants but certainly not panic. our research program, like those of many vaccine developers around the world, is now focused on these variants, asking the question, can we develop vaccines specific to those variants very quickly? how much difference would that make? how long would it take? and that's something that needs to go forward very rapidly. >> now to be clear, steph, the evidence is that other vaccines like the pfizer vaccine, johnson & johnson are still able to prevent infection, and tackle mild disease, even in the south african variant, even, for example, in the brazilian variant. one scientist saying in the past few days every time there's a new infection you effectively buy the virus a lottery ticket. the more virus there is in the world, the more lottery tickets the more it is able to adapt and overcome vaccines meaning this more vaccines will have to be changed to tackle these new variants, steph. >> that is not good new

. >>> and south africa has now put a hold on the use of the astrazeneca/oxford university vaccine afternst the country's strain of the virus. the extremely contagious variant has now reached at least 32 countries, including here in the united states, and those developments come nearly a week after 1 million new doses of the astrazeneca oxford vaccine arrived in south africa. joining us now, dean of the national school of tropical medicine at baylor college of medicine and co-director of the texas children's hospital center for vaccine development, dr. peter hotez. dr. hotez, thank you so much for starting off your morning oh so early with us. we really appreciate you taking some time out of your day. and i want to start with that south africa strain and the astrazeneca/oxford vaccine. does it concern you that they have stopped using this because they found it to be not effective? what data are they working off of and what should we take away from this decision. >> kasie, good morning. the clinical trials were done mostly in younger people, but it showed that the vaccine, although it had

reports out of france, sweden, austria of local groups asking for the moderna vaccine over the oxford university and astrazeneca. there is a difference in every case. oxford and astrazeneca is around about 63% effective. the moderna vaccine around 95% effective according to the figures. but of course all of these doses have to be used. i can give you an example just here in london, i witnessed the on which si on that it of that where people were asking for ox ford vaccine because of national pride that it was developed here in the uk. and in these vaccinationit of t were asking for ox ford vaccine because of national pride that it was developed here in the uk. and in these vaccination centers, you have to explain your medical history, you have to explain any symptoms that you might be having and now you might have to explain the efficacy. i was at one where the primary language wasn't even in english, so imagine having to do that in multiple languages. it is a complicated picture and it will only raise that vaccine hesitancy concern around the xw globe. >> crazy to hear people talking about it as a shelf warmer

begin with the promising vaccine news here is miguel almaguer >> reporter: another shot in the arm in the battle against covid. a new study from oxford university showing astrazeneca vaccine not only protects people from getting sick but from spreading. not yet peer reviewed. a vaccine reducing transmission by 67% it was also shown to be 76% effective at preventing disease after just one dose. it could be authorized for use in the u.s >> we have an impact on infection and transmission >> reporter: it comes amid growing concerns over new variants over taking the u.s. this 35-year-old father of two in alabama is one of the first known death from the u.k. mutant strain which researchers believe it is up to 40% infectious >> if they become dominant, we need to upgrade the vaccine, that's the direction we are going right now. >> reporter: the biden administration announced the new federal state partnership launching two mass vaccination sites in california, the first of 100th nationwide, it is aimed at closing the gap at vaccine access in under served communities. >> this is an equity driven community based partnership. >> reporter: in east oakland where they'll vaccin

scientists are turning their attention to how to adapt vaccines to make sure they work against all new variants. astrazeneca and oxford universityid vaccine ready for the autumn. our medical editor, fergus walsh, reports. the scientists at oxford who created the astrazeneca vaccine are continually monitoring how coronavirus is evolving. the current vaccine is thought to give good protection against new variants, but they're working on tweaking the jab to make it future—proof. the scientist who's leading the research says it's relatively simple to redesign the vaccine. it's not difficult to put a different antigenic insert into the vaccine. so, we don't want to panic and say that we must have a new version of the vaccine now but on the other hand we are getting prepared, so that if it turns out we do need a new version, we will be ready to start using it. it'sjust going to be a sharp scratch, 0k? those on the oxford vaccine trials were shown to have 76% protection from a single dose, which lasted three months, rising to 82% protection, with the second shot. you'll be doing swabs every week at home. it's also the first time a covi

scientists are turning their attention to how to adapt vaccines to make sure they work against all new variants. astrazeneca and oxford universityhave a �*next generation�* covid vaccine ready for the autumn. our medical editor fergus walsh reports. the scientists at oxford who created the astrazeneca vaccine are continually monitoring how coronavirus is evolving. the current vaccine is thought to give good protection against new variants, but they�*re working on tweaking the jab to make it future—proof. the scientist who�*s leading the research says it�*s relatively simple to redesign the vaccine. it�*s not difficult to put a different antigenic insert into the vaccine. so, we don�*t want to panic and say that we must have a new version of the vaccine now but on the other hand we are getting prepared, so that if it turns out we do need a new version, we will be ready to start using it. it'sjust going to be a sharp scratch, ok? those on the oxford vaccine trials were shown to have 76% protection from a single dose, which lasted three months, rising to 82% protection, with the second shot. you�*ll be doing swabs every week at hom

astrazeneca. early data from a trial shows the covid-19 vaccine offers only limited protection against the south african variant. study conducted by south african university and oxford university which helped develop astrazeneca's vaccine. it has reduced efficacy against that strain, no one who has received it has been hospitalized or died. astrazeneca vaccine has not yet been authorized for use in the united states. >>> learning new details of how a woman from california got a personal call from president joe biden. 47-year-old michelle featured in a short video the white house released today, the president calling her to talk about a letter urging him not to forget those struggling financially because of covid-19. she lost her job at san francisco-based company in july. volker told us she wrote the letter to serve as example to her daughter. >> my daughter had watched things happen at capitol and wanted to demonstrate to her writing a letter would be more impactful than breaking windows. somehow or another it worked. >> the short conversation was focused on how the loss of a job can mean so much more than the loss of paycheck. also talked about vaccines. and her d

>> reporter: 300 children in the uk as young as 6 are enrolling in a small astrazeneca vaccine trial through oxford university. it is the first time a covid vaccine has been tested on anyone younger than 12. pfizer, moderna and johnson & johnson are expected to start trials for this younger group in the spring. >> would you put your kids in a trial? >> i don't know. >> reporter: once there are more trials for kids, would you feel comfortable getting your child vaccinated? >> absolutely. >> reporter: the mixed emotions don't end with the adults. >> it would be great because we would get the vaccine, but then again i hate shots. >> reporter: but 11-year-old best friends jaya and dominic hope the trials and needles get them one step closer to the classroom. >> i like playing sports, so it would be fun to go back. >> it has been really hard. like just not being able to see anybody. >> reporter: maria gill is not convinced vaccines are safe. >> to me i believe they came up with this method of a vaccine too soon. i'm just not a believer. >> we have to acknowledge everybody's concerns and not dismiss them. >> report

>> reporter: 300 children in the uk as young as 6 are enrolling in a small astrazeneca vaccine trial through oxford university. it is the first time a covid vaccine has been tested on anyone younger than 12. pfizer, moderna and johnson & johnson are expected to start trials for this younger group in the spring. >> would you put your kids in a trial? >> i don't know. >> reporter: once there are more trials for kids, would you feel comfortable getting your child vaccinated? >> absolutely. >> reporter: the mixed emotions don't end with the adults. >> it would be great because we would get the vaccine, but then again i hate shots. >> reporter: but 11-year-old best friends jaya and dominic hope the trials and needles get them one step closer to the classroom. >> i like playing sports, so it would be fun to go back. >> it has been really hard. like just not being able to see anybody. >> reporter: maria gill is not convinced vaccines are safe. >> to me i believe they came up with this method of a vaccine too soon. i'm just not a believer. >> we have to acknowledge everybody's concerns and not dismiss them. >> report

vaccines. new research from oxford university suggest the protection provided by the first dose of the oxford astrazenecaccines cannot make us invulnerable, and no vaccine has ever given 100% protection to everybody, the evidence increasingly shows that our vaccines achieve this crucial objective, to reduce death and serious illness from those major strains of covid that have been subject to research. and in the days leading up to our viewpoint in the week of the 15th of february, we will accumulating even more data, helped by nhs test and trace, so we can begin to chart a way ahead, starting if the data allows, with the reopening of schools on march the reopening of schools on march the 8th, and i will be setting out as much as we can about that road map forward on february the 22nd. and although today there are some signs of hope, the numbers of covid patients in hospital are beginning to fall for the first time since the onset of this new wave, the level of infection is still alarmingly high, and i am sorry to say that we have lost another 1322 lives in the last 24 hours alone and our hearts again go

is jubilation over the vaccine, there are still obstacles ahead, and it is too early to take a break. laura kuenssberg, bbc news. the pharma giant astrazeneca, and oxford universityxt generation" covid vaccine ready for the autumn. the newjab will help to give protection against some of the latest variants discovered recently. the health secretary, matt hancock, said the latest research indicating the oxford—astrazeneca vaccine might reduce the spread of the virus was "superb news", as our medical editor fergus walsh reports. the scientists at oxford who created the astrazeneca vaccine are continually monitoring how coronavirus is evolving. the current vaccine is thought to give good protection against new variants, but they're working on tweaking the jab to make it future—proof. the scientist who's leading the research says it's relatively simple to redesign the vaccine. it's not difficult to put a different antigenic insert into the vaccine, so we don't want to panic and say that we must have a new version of the vaccine now but on the other hand we are getting prepared, so that if it turns out we do need a new version, it will be ready to start using it. it'sj

the committee also heard from sarah gilbert, who led the team behind the oxford university/astrazeneca vaccinene roll—out to get as many people as possible protected and we need to make sure that nothing can slow that down. so, the more people we have given protection from the vaccine, the less transition we will see but we also need to be aware that the vaccine cannot be used and everyone immediately. we currently are not vaccinating children and there will be transmission amongst children. so, we have to use the other measures that we also have available to us to keep the transmission of virus as low as we possibly can. we cannot allow only the vaccines to do all the work of protecting the population while at the current time in the uk, we still have relatively high levels of transmission. and she warned there was a danger that if lockdown measures were lifted too quickly, transmission would increase leading to variants that couldn't be neutralised as effectively by the vaccine. now, more than 30 conservative mps have urged the government to go further to protect leaseholders living in flats

health organization has granted an emergency authorization to the coronavirus vaccine made by astrazeneca and oxford universityve should allow astrazeneca's partners to ship millions of doses to countries taking part in the u n backed program to tame the pandemic the astrazeneca vaccine was approved for emergency use in the united kingdom at the end of december but that vaccine has not yet been approved for use here in the united states. and in response to all the new variants the makers of covid-19 vaccines are making changes to guard against them health officials say many of the new covid-19 vaccines. >>aid was new flexible technology. that's easy to upgrade, but the challenge is deciding. if the virus has mutated enough that it's time to modify vaccines and what changes to make. they're looking at the global flu vaccine system and using that as a guide to handle similar decisions about covid vaccines. now it's time to talk about our weather kron 4 is a chief meteorologist lawrence karnow joins us now with a look ahead at the rest of the lords. >>we saw some rain earlier today any more on the way yeah we may

leigh-ann: according to data from oxford university, astrazeneca's covid vaccine is 82% effective withit may also make it harder to pass on the virus with a report showing a two thirds drop in transmission after the first dose. russia has jelled opposition leader alexei navalny for two years and eight months. he was arrested last month on his return from germany, where he had been recovering from a nerve agent attack. in a defiant statement, he said someone did not want him to return to russia, referring to president putin. the end of an era for amazon. later in the year, jeff bezos will step down to focus on innovation, replaced by the head of the cloud dealer, andy jassy. global news 24 hours a day, on air and at bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries, i am leigh-ann gerrans. this is bloomberg. francine? francine: we are also getting data out of the u.k. that pmi figure, for the month january, for services is what i am looking at, a touch better than expected. if you look at the numbers, 39.5. it is an ugly number because an

health organization has granted emergency use authorization for the coronavirus vaccine made by astrazeneca and oxford university. the move should allow the u. n. health agencies partners to ship millions of doses two countries worldwide as part of a u. n backed program to ease the pandemic. the astrazeneca vaccine is only the second to be green, lighted by the world health organization. in december, the agency approved the visor by on tech vaccine. after the break. a search is underway for a missing 17 year old football player after he vanished, mid span on the richmond san rafael bridge. also just days after a contentious lawsuit was dropped, the president of the toronto raptors is speaking out about his altercation with an alameda county sheriff's deputy at oracle arena. want to save hundreds on your wireless bill? with xfinity mobile you can. how about saving hundreds on the new samsung galaxy s21 ultra 5g? you can do that too. all on the most reliable network. sure thing! and with fast nationwide 5g included at no extra cost. we've got you covered. so join the carrier rated #1 in customer satisfaction. and

there has been no comment from astrazeneca or oxford university on this study but crucially, it's been reported that the vaccinen hospital admissions. yesterday the head of astrazeneca said it wouldn't be surprising if levels of protection dip with the south african variant given what we have seen in early results from other vaccines. developers are working on tweaking their vaccines to cope with emerging variance. it is something that already happens with the flu jab and it could be in future that we need to have a booster shot each year. this that we need to have a booster shot each year.— shot each year. as the global race to produce _ shot each year. as the global race to produce and - shot each year. as the global| race to produce and distribute covid—i9 vaccines continues, china appears to have made huge strides. sinovac and sinopharm are already making their way abroad. speight cautioned that the data range for people aged 16 and above is limited, their i6 and above is limited, their drugs have received approval. from mask diplomacy to vaccine diplomacy. china has been working hard to change global perce

now, astrazeneca, of course, uk oxford university— astrazeneca, of course, uk oxford university vaccineare essentially similar. the south african trial was in young _ similar. the south african trial was in young adults and reported mild disease, — in young adults and reported mild disease, and a reduced level of protection _ disease, and a reduced level of protection against infection. but that really doesn't change my view that really doesn't change my view that it _ that really doesn't change my view that it is _ that really doesn't change my view that it is still rather likely to have — that it is still rather likely to have an _ that it is still rather likely to have an effect on severe disease. and to _ have an effect on severe disease. and to people who are on the edge, going. _ and to people who are on the edge, going, shall i have this current vaccine — going, shall i have this current vaccine or— going, shall i have this current vaccine or shower i kind of hang on for a _ vaccine or shower i kind of hang on for a south — vaccine or shower i kind of hang on for a south african

. >>> for the first time the university of oxford plans to test its covid vaccine in children. this is the shot being produced and distributed by astrazeneca. researchers are looking for 300 volunteers between the ages of 6 and 17. most will get the covid shot. the rest will get a controlled meningitis vaccine. >> this is the first evaluation

professor sarah gilbert leads the team at oxford university that produced the astrazeneca vaccine.will still provide protection against the threat of serious illness cause by coronavirus. what we are seeing from other vaccine developers is that they have a reduction in efficacy against some of the variant viruses and what that is looking like is that we may not be reducing the total number of cases, but there is still protection in that case against deaths, hospitalisations and severe disease, so that pushes us more back to the first scenario with the pyramid of cases that i was talking about. maybe we won't be reducing the number of cases as much, but we still won't be seeing the deaths, the hospitalisations and severe disease and that is really important for health care systems. even if we are having mild and asymptomatic infections, to prevent people from going to hospital with covid would have a major effect. the new version of the vaccine will generate antibodies that recognise the new variant and then it will be very much like working on flu vaccines, so people will be famili

vaccines perform in that age group. the companies may test them in younger children. university of oxford plans to test its astrazenecane on children later this month. university is looking for 300 volunteers ranging in age from 6 to 17. researchers say that while most children don't get severely ill with covid, it is very important to get a vaccine that is safe for children. president biden is set to visit visors plant in michigan on thursday. that's where the covid-19 vaccines being manufactured. this facility is running three shifts nonstop, including weekends and holidays. just last week, the president announced the united states plans to secure 200 million more doses from visor and moderna by july in new york state lawmakers are calling for an investigation into governor andrew cuomo. his administration is accused of purposely keeping information about the true number of coronavirus deaths at nursing homes from st lawmakers, special advisor to the governor said the information was withheld out of fear that the death toll would be used against them by the trump administration. we need a full investigation. it is t

health organization has granted emergency authorization for the coronavirus vaccine made by astrazeneca and oxford university. >>the move should allow astrazeneca's partners to ship millions of doses to countries taking part in a u n backed program to tame the pandemic the astrazeneca vaccine was approved for emergency use in the uk at the end of december. and in response to all the new variants the makers of covid-19 vaccines are making changes to guard against them. health officials say many of the new back covid-19 vaccines are made with new flexible technology that is easy to upgrade. now the challenge is deciding if the virus has mutated enough that it's time to modify vaccines and what changes to make. they're looking at the global flu vaccine system and using that as a guy to handle similar decisions about covid vaccines. and doctor fauci has won a 1 million dollar award from a private israeli foundation for courageously defending science as they say during the coronavirus pandemic the dan david foundation announced the honor today saying doctor fauci had earned over a half a century. contributions to

the world health organization has granted an emergency authorization to the vaccine made by astrazeneca and oxford university. they say that should make it possible to ship millions of doses to countries taking part in a u n program, the astrazeneca vaccine was approved for emergency use in great britain that was in december it has not yet been approved in the u.s.. new research says the pfizer vaccine is 94% effective in blocking covid symptoms and people over 55, this is an israeli study. it also says the vaccine makes its 92 per makes up 92% less likely somebody will get a severe case of the virus. these results are for got both doses of the pfizer vaccine. >>well another big story we're following tonight cal iso and pg and e asking customers to voluntarily conserve energy tonight. the reason is the record breaking winter storm that has been creating dangerous conditions across the nation. officials say conserving energy here in the evening hours helps ease the stress to grid conditions in other areas of the west. the heavy snow and the freezing temperatures have shut down airports canceling thousands of

leigh-ann: oxford university and astrazeneca are developing a new vaccine to tackle the south africannt of coronavirus. it comes after early data shows the jab has limited effectiveness against cases caused by the mutation. the scientists leaving the program says it is likely the new vaccine will be available by autumn. myanmar has seen its biggest antigovernment demonstrations in over a decade as people demand the release of aung san suu kyi and other civilian leaders. the army shut down the internet. according to a controversial assessment from the u.k. foreign office, you -- the queue is irreversible and enter reaction be on is unlikely. one of the biggest sports of the , the super bowl, the tampa bay buccaneers beat the kansas city chiefs by 31-9. it is tom brady's up when and his first without the new england patriots. global news 24 hours a day, on air and at bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries, i'm leigh-ann gerrans. this is bloomberg. francine? francine: let's stay with that story. go box is what i was taught on bl

. 300 kids in the uk as young as 6 to 12 years old are enrolling in a small astrazeneca vaccine trial through oxford universitymoderna, and johnson & johnson are expected to start trials for this younger group in the spring. dr. george rutherford from ucsf assures parents the vaccine will be safe. >> parents have concerns about getting their kids vaccinated against everything. this is i think a much more heavily studied. it uses new technology, which should be safer. >> they want know when they're going get them. >> reporter: san francisco pediatrician lisa dana says parents of her patients are asking for the vaccines already. a safeguard for when in-person learning resumes. >> i the not think they will be released until they're safe, and i do trust that they'll be safe when they're available. >> reporter: but not all parents are convinced. turkey, me, i believe they came up with this method of a vaccine too soon. i'm just not a believer. >> reporter: some doctors say while immunizing children may be important for herd immunity, it should not be a prerequisite for returning to the classroom. >> once teachers a

vaccines. new research from oxford university suggests the protection provided by the first dose of the oxford astrazenecane kicks in after three weeks and lasts right the way through to the booster at three months. and research also shows that the oxford astrazeneca vaccine seems likely to reduce transmission to others. the prime minister went on to say that while today's news was hugely positive, more data is required before considering any relaxation of the covid restrictions. nonetheless, the uk government will take great satisfaction in those numbers. per capita, israel still leads the way in vaccinating its citizens, but the uk and us are now making significant progress. remember — at least 70% of the population in a country has to be vaccinated before we can think about reaching herd immuninty. —— herd immunity. in the us, the cases and hospitalisations continue to fall, though the head of the cdc said today the spread of the variants remains a cause for concern. not wearing masks and participating in in person social gatherings have contributed to the variants' spread. we must take prevention and

health organization has granted an emergency authorization to the coronavirus vaccine might made by astrazeneca and oxford university. the move should allow astrazeneca's partners to ship millions of doses to countries taking part in a u n backed program to tame the pandemic the astrazeneca vaccine was approved for emergency use in the united kingdom at the end of december but that vaccine has not yet been approved for use here in the united states. >>vaccine makers are making changes to guard against newt haitians. they say that a lot of the vaccines. we'll be easy to upgrade, but the challenge will be in deciding when the virus has mutated enough that it's time to modify the vaccines. what kind of changes to make and they're looking at the global flu vaccine system and using that as a guide. >>time for another look at the forecast which apparently includes more blustery weather him la raza standing by with more on the winds coming our it has been whipping around the bay area this afternoon and evening and continues out there for tonight. >>stepping outside get a little chilly out there with the winds continue to b

they're working on changing these vaccinations so they can deal with future variants. for example, oxford university and astrazeneca say they'll have a new vaccine by the fall to deal with that south africa variant because of that limited efficacy, and also making plans for possibly annual vaccinations. take a listen to what the vaccine minister said yesterday. >> we see very much probably an annual and a booster in the autumn and the way we do with flu vaccinations where you look at what variant of virus is spreading around the world. you rapidly produce a variant of vaccine and then begin to vaccinate and protect the nation. >> reporter: so the authorities here have already made agreements with manufacturers around the world to try to be prepared to create these future vaccines for these future variants. in addition to the vaccines, of course, there's very tough travel restrictions. you can't come into the uk unless you show a negative test. you can't leave the uk unless you have an essential travel reason. this is the first country hit hard by one of these variants and they don't want to live that nightmare agai

no comment from astrazeneca or 0xford comment from astrazeneca or oxford university on the study but crucially it has been reported that the vaccineting deaths and hospital admissions. the head of astrazeneca said yesterday it would not be surprising if levels of protection dip with the south african variant given what we have seenin african variant given what we have seen in early results from other vaccines, and developers are already working on tweaking their vaccines to cope with new emerging variants. something which will be happens with the flu jab and it might in future mean that we have to have a booster shot each year. mean that we have to have a booster shot each year-— shot each year. thanks for “oining us. tomorrow morning andrew marr will be joined by the architect of the oxford vaccine — professor sarah gilbert — and the vaccines minister, nadhim zahawi. that's at 9am here on bbc one. myanmar has seen the biggest day of protests since the military took power in a coup on monday. thousands of workers and young acitivists took to the streets in the city of yangon as military rulers implemented a near total internet shu

organization has granted emergency youth ansari ization of the coronavirus vaccine created by astrazeneca and oxford university. this move should allow the u. n health agencies partners, his ship millions of doses two countries worldwide, is part of a u. n backed program to tame the pandemic. the astrazeneca vaccine is only the second one reminded by the world health organization in december of the agency provided excuse me approved the thighs or violent tec vaccine. well still ahead this evening a winter storm record cold temperatures, forcing rolling blackouts more on the frigid conditions that's affecting more than a dozen states and the organizer of napa valley's bung rock festival sued the alleged attack at the center of the lawsuit. and a very weather, lots of clouds, even some scattered showers throughout the day, but it looks like a break as we had went into what tuesday it more sunshine. what tuesday it more sunshine. what about more rain chances? we'll ♪ ♪ ♪ ♪ ♪ ♪ drivers, leaving them nowhere to go. a frigid winter storm is hitting a large swath of the country right now, bringing heavy snow and some

early data suggested the current vaccine from astrazeneca and oxford university has limited impact on the mild disease caused by the variant. and that a new shot should be ready by autumn. a former u.s. secretary of state, george schultz, has died. he served under ronald reagan from more than six years and frequently clash with more ideological members of the administration. the ivy league educated economist was labor secretary before that, treasury secretary under richard nixon. he was 100 years old. global news 24 hours a day, on air and at bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries, i'm ritika gupta. this is bloomberg. tom? tom: correlated, equities, bonds, currencies, commodities, accuray's -- equities continuing to lift. futures up 11, the vix does not give me much information right now. what does get me information is the rate market, and there you have two year lower, which is very interesting as the 10 year goes higher come out to a mighty 1.19%. we are on a 2% watch with a 30 year bond. brent crude, $60 a barrel. francin

a new oxford university study found the astrazeneca vaccine keeps people from getting sick and may stop them from passing on the virus. we'll get to that. leadoff guests, two new faces. reed epstein with the "new york times" and anna palmer, founder and ceo of punch bowl news. a new d.c.-based news service created with politico veteran, and eugene robinson, pulitzer prize winning columnist for the "washington post." good evening to you all. anna, what just happened? your organization reported that members of the republican caucus gave the qanon congresswoman a standing ovation at close of her remarks. you saw mccarthy come out and pretend to mispronounce and not know what qanon is. the flags on the capitol lawn outside his office during the insurrection notwithstanding. in your view, what just happened? >> we're seeing the fight for the soul of the republican party play out in real time in the house. basically you had kevin mccarthy, leader of the house republicans, try to thread the needle and have it both ways. not only did he not denounce greene and her conspiracy theories and racism

. >> oxford university and astrazeneca are developing a new vaccine to tackle the south africa variant of coronavirus. it comes after early data shows the shot has limited effectiveness against mild cases caused by the mutation. the scientists leading the program say it is very likely the new vaccine will be available by the autumn. myanmar has seen its biggest antigovernment restriction in over a decade as people determine that people demand the release of aung san suu kyi and other leaders. according to a confidential assessment from the u.k. foreign office, the coup is irreversible and any action beyond sanctions is unlikely. one of the biggest sport events of the year of the super bowl, the tampa bay buccaneers beat the kansas city chiefs 31-9. it is the buccaneers second nfl title and the first in decades. global news 24 hours a day on air and on quicktake by bloomberg, powered by more than 2700 journalists and analysts in more than 120 countries. this is bloomberg. manus: i will pick it up from here. we have got some breaking lines coming in on softbank. for the third quarter, ne

people receiving at least one dose of coronavirus vaccine worldwide has now equaled the total number of infections. and astrazeneca and oxford universityng on a reengineered shock that works against all mutations with a rollout target in the third quarter. moderna is offering its vaccine to south africa. in other news, the world health organization team investigating the origins of the virus have wound up their visits with a lab in wuhan. the chinese are rejecting accusations the virus spread from there. the who team was accompanied by chinese officials and has given no details yet about the visit. staying on china, it is cutting capacity in flights from mainland carriers over lunar new year as coronavirus numbers rise. departures will be at least 10% more than normal. that means the usual surge in travel demand will not happen this year as the aviation sector struggles to remain viable. the economic forum has rescheduled its special annual meeting in singapore due to trav q

we got updates on vaccines from oxford university, astrazeneca and the uk, known as sputnik v both are being used in those countries and others it's reassuring to see further results suggesting they do, indeed, work the russian vaccine was shown to be 92% effective in preventing symptomatic covid-19 in the trial of 20,000 people with no real safety issues astrazeneca showed overall east of icacy of 67%. when the two doses were spaced 12 weeks apart, the efficacy went up to 82%, supporting the strategy adopted in the uk of spacing doses tout give more first doses of the vaccine the oxford group also suggests their vaccine provides some protection three weeks after a single shot. out to three months, and that the two doses may cut down on transmission here in the u.s., the government has not contracted for the russian vaccine, but it has ordered doses of the astrazeneca one and results from a large u.s. trial are expected in march. shep >> meg tirrell, thanks very much >>> president biden's covid relief plan. big, bold but not bipartisan. >> needs of the american people are so demanding,

timetables, but while there is jubilation over the vaccine, there are still obstacles ahead, and it is too early to take a break. astrazeneca and oxford universityumn, should it be needed. the newjab will help to give protection against some of the variants that have been discovered recently. today, the health secretary matt hancock said research suggesting the current oxford—astrazeneca vaccine may reduce the spread of coronavirus is "superb", and will "help us all to get out of" the pandemic. 0ur medical editor fergus walsh has more. the scientist at oxford who created the astrazeneca vaccine are continually monitoring how coronavirus is evolving. the current vaccine is thought to give good protection against new variants, but they are working on tweaking the jab to make it future proof. the scientist who is leading the research says it is relatively simple to redesign the vaccine. you have a simple to redesign the vaccine. ym. have a different antigenic insert into the vaccine, so we don't want to panic and say that we must have a new version of the vaccine now but on the other hand we are getting prepared, so that if it turns out we do need

scientists at oxford university and astrazeneca say they're working on the next generation of covid vaccinesthat theirjab can be adapted to work against different strains of the virus. the virus is already mutating, first here in the uk, then in brazil and south africa. hospitals in portugal are struggling to cope with a sharp rise in coronavirus cases. nearly half of the country's 13,000 covid fidelity is occurred just last month. it has been a worrying time for a country that had been doing better than its european neighbours battling the outbreak —— fidelity�*s. germany has sent help. now on bbc news it's hardtalk with stephen sackur. welcome to hardtalk, i'm stephen sackur. alexander lukashenko still sits in the presidential palace in belarus, six months after an election which he probably lost. europe's last de facto dictator continues to brutally repress protests and imprison political opponents. my guest is sviatlana tsikhanouskaya, the woman who believes she won last august's vote, and who, from exile, calls herself the leader of democratic belarus. but is toppling lukashenko any clo

vaccines could be authorized for young children coming into the first grade in the u.s. as early as september. and researchers at oxford university are now beginning clinical trials for the astrazenecane with children as young as six in the u.k. so how significant and potentially promising is this to you? >> i think it's an important move that we go in the direction of starting to get our children vacci vaccinated. we've proven these vaccines are safe for adults, so the natural progression would be to prove that it's safe for children. pfizer tested their vaccine in those as young as 16 years old, and they actually expanded their trials, pfizer and moederna, to go down to the age of 12, and the as trtrazeneca is testing o children as young as 12. i think that will be an important mitigation strategy in order to get schools fully reopened and kids re-engaged into the classroom. >> in terms of mask wearing, there are states and communities relaxing that, and the latest projection from the university of washington's institute say that at least 614 million people will have died by june 1. what do you say about loosening those mask restrictions? >> now is not the time. the deaths have be

a new oxford university study found the astrazeneca vaccine not spreading the virus. we'll have more on that later in the broadcast. but with that, let's bring in our lead-off guests on this wednesday night. we welcome two new faces to our broadcast. wade epstein, political reporter with new york city and anna palmer, veteran founder c.e.o. of punch bowl news. we'll get to that name in a bit, a new d.c. name she created with jake sherman. and back with us tonight, eugene robinson, pulitzer prize winning columnist for the washington post. good evening and welcome to you all. i'd like to begin with you. what just happened? your organization reported that members of the republican caucus gave the qanon congresswoman a standing ovation at the close of her remarks. you saw mccarthy come out and pretend to mispronounce and not know what qanon is. the flags on the capitol lawn outside his office during the insurrection, notwithstanding. so in your view, what just happened? >> we're seeing the fight for the soul of the republican party play out in real-time in the house. basi

pharmaceutical company, astrazeneca, says a small trial suggests the coronavirus vaccine it's developed with oxford universitydoes not appear to offer much protection against mild or moderate disease, caused by the south africa variant. but the firm believes the jab would protect against severe disease. thousands of indian farmers brought some of the country's major roads to a standstill to show their opposition to new agriculture reforms, that they say would leave them out of pocket. dozens were arrested with more than 50,000 members of the security services being deployed for the protests. a leaked document has revealed that borisjohnson is considering a reform of the nhs in england. the changes could see a reduced role for the private sector and sweep away changes introduced by david cameron's government in 2012. nhs commissioners would no longer be required to invite private companies to bid to run services and there would be more focus on hospitals and social care services working together to improve patient care. our health correspondent katharine de costa reports. an ageing population brings with it th

a new study from oxford university says the coronavirus vaccine it developed with astrazeneca not onlygnificantly. researchers found the jab provided good protection even when there was a gap of 12 weeks between the first and the second doses. 0ur medical editor fergus walsh has more on this — and on growing concern — about the way coronavirus is showing its ability to change genetically. a little scratch coming there. more good news on vaccines, the oxford astrazeneca jab offers sustained protection against covid disease of 76% for at least three months after the first shots, supporting the uk decision to delay second doses. inside there is a patient data sheet about the astrazeneca vaccine you've had today. 0k. 0k? the oxford jab may also cut transmission, those vaccinated were far less likely to carry any coronavirus, meaning each person immunised may indirectly protect others. we found there was a big reduction in people being infected with coronavirus and because they were not infected, they can't go on and transmit to other people. and so that is really important in potentially c